Login to Your Account



Search

Search results

Pharma: Clinic roundup

Avillion Group , of London, said it entered an exclusive collaborative development agreement with Pfizer Inc. , of New York, to conduct a Phase III trial of Bosulif (bosutinib). (BioWorld-Today-2014-01-10) ...

BioWorld Today - Staff - 2014-01-10 01:00 - 0 comments - 0 attachments

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2007-01-16) ...

BioWorld Today - Staff - 2007-01-16 01:00 - 0 comments - 0 attachments

Clinic Roundup

Biogen Idec Inc. , of Weston, Mass., and Swedish Orphan Biovitrum AB , of Stockholm, Sweden, disclosed positive results from A-LONG, a Phase III trial that evaluated a long-lasting clotting factor candidate in people with hemophilia A. (B ...

BioWorld Today - Staff - 2013-12-06 01:00 - 0 comments - 0 attachments

Clinic Roundup

• Esperion Therapeutics Inc. , of Plymouth, Mich., reported top-line results from a Phase IIa trial of ETC-1002 for hypercholesterolemia in patients with a history of intolerance to two or more statins. (BioWorld-Today-2013-06-10) ...

BioWorld Today - Staff - 2013-06-10 00:00 - 0 comments - 0 attachments

Clinic Roundup

• Galectin Therapeutics Inc. , of Norcross, Ga., said five of the eight patients have been enrolled and infused in the first cohort of its blinded Phase 1 trial of GR-MD-02 for patients with nonalcoholic steatohepatitis (NASH or fatty liver disease) ...

BioWorld Today - Staff - 2013-11-13 01:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Baxter International Inc. , of Deerfield, Ill., said it started dosing patients with malignant solid tumors in a Phase I study of a fully human recombinant anti-macrophage migration inhibitory factor (MIF) monoclonal antibody. (BioWo ...

BioWorld Today - Staff - 2012-09-06 00:00 - 0 comments - 0 attachments

Clinic roundup

Brainstorm Cell Therapeutics Inc. , of New York and Petach Tikvah, Israel, said the FDA approved commencement of its phase II trial with Nurown in patients with amyotrophic lateral sclerosis (ALS). (BioWorld-Today-2014-04-29) ...

BioWorld Today - Staff - 2014-04-29 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Astellas Pharma US Inc ., of Northbrook, Ill., part of Astellas Pharma Inc., reported that efficacy and safety data of the isavuconazole invasive aspergillosis study (SECURE) were presented at the European Congress of Clinical Microbiology and Infect ...

BioWorld Today - Staff - 2014-05-15 00:00 - 0 comments - 0 attachments

Clinic roundup

Amgen, of Thousand Oaks, Calif., said data from the phase III LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy-2) study were published in the Journal of the American Medical Association . ...

BioWorld Today - Staff - 2014-05-15 00:00 - 0 comments - 0 attachments

Clinic roundup

Basilea Pharmaceutica Ltd. , of Basel, Switzerland, reported that a phase III trial showed its antibiotic ceftobiprole to demonstrate more rapid clinical responses in hospital-acquired pneumonia and community-acquired pneumonia than a comparator regi ...

BioWorld Today - Staff - 2014-05-14 00:00 - 0 comments - 0 attachments